Skip Navigation
 
Home | About CDC | Media Relations | A-Z Index | Contact Us
  
Centers for Disease Control and Prevention
CDC en Español 
 

Sexually Transmitted Diseases

Home  /  Surveillance  /  2003 Reports  /
National Profile
National Profile
  Gonorrhea   1  2  3

 << Previous Table of Contents Next >> 

Figure 16. Gonorrhea — Rates by race and ethnicity: United States, 1981–2003 and the Healthy People 2010 target

Figure 16. Gonorrhea — Rates by race and ethnicity: United States, 1981–2003 and the Healthy People 2010 target
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

Figure 17. Gonorrhea — Age- and sex-specific rates: United States, 2003

Figure 17. Gonorrhea — Age- and sex-specific rates: United States, 2003
Note: See Table 20.

Figure 18. Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2003

Figure 18. Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2003
*States reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2003.
Note: Includes states that reported gonorrhea positivity data on at least 500 women aged 15-24 years screened during 2003 except for Minnesota which submitted gonorrhea positivity data for July-December 2003 only.
SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention

Figure 19. Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2003

Figure 19. Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2003

Figure 20. Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2003

Figure 20. Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2003
Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline-resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline-resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR= chromosomally mediated tetracycline-resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin and tetracycline-resistant N. gonorrhoeae.

Figure 21. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2003

Figure 21. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–200
Note: Resistant isolates have ciprofloxacin MICs ≥ 1 µg/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 µg/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

Figure 22. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior, 2001–2003

Figure 22. GISP — Percent of Neisseria gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior, 2001 – 2003

 << Previous Table of Contents Next >> 

Page last modified: November 15, 2004
Page last reviewed: November 15, 2004 Historical Document

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention